Literature DB >> 18077441

Chronic atrial fibrillation ablation impact on endocrine and mechanical cardiac functions.

Frédéric Sacher1, Jean-Benoît Corcuff, Philippe Schraub, Valérie Le Bouffos, Agnès Georges, Samuel O Jones, Stéphane Lafitte, Pierre Bordachar, Mélèze Hocini, Jacques Clémenty, Michel Haissaguerre, Laurence Bordenave, Raymond Roudaut, Pierre Jaïs.   

Abstract

AIMS: Assess the impact of persistent/permanent atrial fibrillation (AF) ablation on endocrine and mechanical cardiac functions. METHODS AND
RESULTS: In all, 43 patients (40 males, 53 +/- 12 years) undergoing persistent/permanent AF ablation had atrial (ANP) and brain natriuretic peptide (BNP) measurements before day 1, 3, and 3 months after ablation. In the same period of time transthoracic echocardiography was performed. With a mean radiofrequency delivery of 98 +/- 29 min, sinus rhythm (SR) was restored in 30 patients (70%) without DC shock. ANP decreased significantly (P < 0.001) with restoration of SR and then increased until day 3 post ablation without reaching the level observed during AF. At 3 months, ANP was significantly lower than day 3 reaching normal value in 28 (65%) patients and being <7 pg/mL in 4 (9%). The BNP followed the same trend with normal BNP level in 23 (53%) patients at 3 months. Identifiable atrial filling waves on the pulsed Doppler transmitral recordings performed between day 2 and day 4 after the procedure were seen in 18 patients (42%). At 3 months, 39 (95%) of the patients with SR during echocardiography had a significant A wave.
CONCLUSION: SR following persistent/permanent AF ablation is associated with a dramatic decrease in natriuretic peptides. At 3 months, despite relatively extensive atrial ablation, endocrine and mechanical cardiac functions are significantly improved.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18077441     DOI: 10.1093/eurheartj/ehm577

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  22 in total

Review 1.  What Is the Appropriate Lesion Set for Ablation in Patients with Persistent Atrial Fibrillation?

Authors:  Jorge Romero; Carola Gianni; Andrea Natale; Luigi Di Biase
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-05

2.  Level Of Natriuretic Peptide Determines Outcome In Atrial Fibrillation.

Authors:  Qi-Xian Zeng; Ming-Fen Wei; Wei Zhang; Yun Zhang; Jing-Quan Zhong
Journal:  J Atr Fibrillation       Date:  2010-01-01

3.  Meta-analysis of randomized controlled trials on atrial fibrillation ablation in patients with heart failure with reduced ejection fraction.

Authors:  Aiman Smer; Mohsin Salih; Yousef H Darrat; Abdulghani Saadi; Raviteja Guddeti; Toufik Mahfood Haddad; Amjad Kabach; Mohamed Ayan; Alok Saurav; Hussam Abuissa; Claude S Elayi
Journal:  Clin Cardiol       Date:  2018-11-19       Impact factor: 2.882

4.  N-terminal pro-B-type natriuretic peptide level at long-term follow-up after atrial fibrillation ablation: a marker of reverse atrial remodelling and successful ablation.

Authors:  Eivind Solheim; Morten Kristian Off; Per Ivar Hoff; Alessandro De Bortoli; Peter Schuster; Ole-Jørgen Ohm; Jian Chen
Journal:  J Interv Card Electrophysiol       Date:  2011-10-13       Impact factor: 1.900

5.  Impact of epicardial ablation of concomitant atrial fibrillation on atrial natriuretic peptide levels and atrial function in 6 months follow-up: does preoperative ANP level predict outcome of ablation?

Authors:  Marek Pizon; Norbert Friedel; Monika Pizon; Miriam Freundt; Michael Weyand; Richard Feyrer
Journal:  J Cardiothorac Surg       Date:  2013-11-28       Impact factor: 1.637

6.  Improvement of left ventricular function after successful radiofrequency catheter ablation in persistent atrial fibrillation with preserved left ventricular ejection fraction: a comprehensive echocardiographic assessment using two-dimensional speckle tracking analysis.

Authors:  Tomoo Nagai; Junko Arakawa; Akira Hamabe; Hirotsugu Tabata
Journal:  J Echocardiogr       Date:  2018-10-01

Review 7.  Interpretation and use of natriuretic peptides in non-congestive heart failure settings.

Authors:  Shih-Hung Tsai; Yen-Yue Lin; Shi-Jye Chu; Ching-Wang Hsu; Shu-Meng Cheng
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

8.  Catheter Ablation for Atrial Fibrillation in Heart Failure Patients: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Shadi Al Halabi; Mohammed Qintar; Ayman Hussein; M Chadi Alraies; David G Jones; Tom Wong; Michael R MacDonald; Mark C Petrie; Daniel Cantillon; Khaldoun G Tarakji; Mohamed Kanj; Mandeep Bhargava; Niraj Varma; Bryan Baranowski; Bruce L Wilkoff; Oussama Wazni; Thomas Callahan; Walid Saliba; Mina K Chung
Journal:  JACC Clin Electrophysiol       Date:  2015-06-01

9.  Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction.

Authors:  Konstantinos P Letsas; Gerasimos S Filippatos; Loukas K Pappas; Constantinos C Mihas; Virginia Markou; Ioannis P Alexanian; Michalis Efremidis; Antonios Sideris; Alan S Maisel; Fotios Kardaras
Journal:  Clin Res Cardiol       Date:  2008-10-30       Impact factor: 5.460

Review 10.  Destruction Of Medium Already Afected By Destructive Disorder: Fibrillating Atria Conceptually Need Therapeutic Help Rather Than Surgical Or Ablative Destruction.

Authors:  Petras Stirbys
Journal:  J Atr Fibrillation       Date:  2014-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.